GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:0010595	positive regulation of endothelial cell migration	3.54E-7	2.39E-3	7.72	714	10	74	8	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, MET  -  met proto-oncogene, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1]
GO:0010594	regulation of endothelial cell migration	1.14E-6	3.83E-3	6.20	714	14	74	9	[NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), MET  -  met proto-oncogene]
GO:0006928	movement of cell or subcellular component	4.47E-6	1E-2	2.32	714	108	74	26	[DST  -  dystonin, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, DPYSL2  -  dihydropyrimidinase-like 2, ADCY3  -  adenylate cyclase 3, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, MYO5C  -  myosin vc, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, MYO5A  -  myosin va (heavy chain 12, myoxin), MYO1E  -  myosin ie, BBS4  -  bardet-biedl syndrome 4, FAT1  -  fat atypical cadherin 1, LAMB1  -  laminin, beta 1]
GO:0061041	regulation of wound healing	5.45E-6	9.21E-3	5.43	714	16	74	9	[KANK1  -  kn motif and ankyrin repeat domains 1, PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:1900046	regulation of hemostasis	6.6E-6	8.92E-3	8.27	714	7	74	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0030193	regulation of blood coagulation	6.6E-6	7.43E-3	8.27	714	7	74	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:1903034	regulation of response to wounding	1.06E-5	1.02E-2	5.11	714	17	74	9	[KANK1  -  kn motif and ankyrin repeat domains 1, PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0010634	positive regulation of epithelial cell migration	1.67E-5	1.41E-2	5.51	714	14	74	8	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, MET  -  met proto-oncogene]
GO:0080134	regulation of response to stress	2.06E-5	1.54E-2	2.39	714	89	74	22	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, KANK1  -  kn motif and ankyrin repeat domains 1, PLAUR  -  plasminogen activator, urokinase receptor, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, ADA  -  adenosine deaminase, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), NUAK1  -  nuak family, snf1-like kinase, 1, RNF135  -  ring finger protein 135]
GO:0050818	regulation of coagulation	2.42E-5	1.64E-2	7.24	714	8	74	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0002699	positive regulation of immune effector process	5.07E-5	3.11E-2	5.63	714	12	74	7	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, STXBP1  -  syntaxin binding protein 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1]
GO:0010632	regulation of epithelial cell migration	5.66E-5	3.18E-2	4.34	714	20	74	9	[NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene]
GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	6.68E-5	3.47E-2	6.43	714	9	74	6	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, ADA  -  adenosine deaminase]
GO:0002819	regulation of adaptive immune response	6.68E-5	3.22E-2	6.43	714	9	74	6	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ADA  -  adenosine deaminase, ANXA1  -  annexin a1]
GO:0002684	positive regulation of immune system process	8.69E-5	3.91E-2	2.78	714	52	74	15	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0043536	positive regulation of blood vessel endothelial cell migration	1.07E-4	4.52E-2	9.65	714	4	74	4	[THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:0050878	regulation of body fluid levels	1.07E-4	4.26E-2	3.71	714	26	74	10	[VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene, ABAT  -  4-aminobutyrate aminotransferase, ADCY3  -  adenylate cyclase 3]
GO:0048585	negative regulation of response to stimulus	1.09E-4	4.09E-2	2.17	714	98	74	22	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, KANK1  -  kn motif and ankyrin repeat domains 1, PXDN  -  peroxidasin homolog (drosophila), TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PRICKLE1  -  prickle homolog 1 (drosophila), PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ADA  -  adenosine deaminase, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), WWOX  -  ww domain containing oxidoreductase, BBS4  -  bardet-biedl syndrome 4, ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1]
GO:0048584	positive regulation of response to stimulus	1.24E-4	4.4E-2	1.93	714	135	74	27	[CADM1  -  cell adhesion molecule 1, HLA-G  -  major histocompatibility complex, class i, g, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, KANK1  -  kn motif and ankyrin repeat domains 1, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, TBL1X  -  transducin (beta)-like 1x-linked, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PLAUR  -  plasminogen activator, urokinase receptor, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, WWOX  -  ww domain containing oxidoreductase]
GO:0001817	regulation of cytokine production	1.42E-4	4.81E-2	3.13	714	37	74	12	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), RNF135  -  ring finger protein 135, ZBTB20  -  zinc finger and btb domain containing 20]
GO:0050778	positive regulation of immune response	1.42E-4	4.58E-2	3.13	714	37	74	12	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, STXBP1  -  syntaxin binding protein 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, ADA  -  adenosine deaminase, FOXP1  -  forkhead box p1, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, RNF135  -  ring finger protein 135]
GO:1904018	positive regulation of vasculature development	1.53E-4	4.7E-2	5.79	714	10	74	6	[THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0045766	positive regulation of angiogenesis	1.53E-4	4.5E-2	5.79	714	10	74	6	[SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:2000145	regulation of cell motility	1.79E-4	5.02E-2	2.63	714	55	74	15	[MET  -  met proto-oncogene, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, DPYSL3  -  dihydropyrimidinase-like 3, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1]
GO:0001819	positive regulation of cytokine production	2.23E-4	6.01E-2	3.45	714	28	74	10	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), RNF135  -  ring finger protein 135, ZBTB20  -  zinc finger and btb domain containing 20]
GO:0040011	locomotion	2.23E-4	5.79E-2	2.32	714	75	74	18	[DST  -  dystonin, MET  -  met proto-oncogene, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, PLAUR  -  plasminogen activator, urokinase receptor, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, MEF2C  -  myocyte enhancer factor 2c, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, MYO5A  -  myosin va (heavy chain 12, myoxin), BBS4  -  bardet-biedl syndrome 4, FAT1  -  fat atypical cadherin 1, ADCY3  -  adenylate cyclase 3, LAMB1  -  laminin, beta 1]
GO:0048522	positive regulation of cellular process	3.16E-4	7.89E-2	1.44	714	315	74	47	[CADM1  -  cell adhesion molecule 1, HLA-G  -  major histocompatibility complex, class i, g, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, ZBTB20  -  zinc finger and btb domain containing 20, NFIB  -  nuclear factor i/b, ARHGEF10  -  rho guanine nucleotide exchange factor (gef) 10, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, PBX1  -  pre-b-cell leukemia homeobox 1, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SASH1  -  sam and sh3 domain containing 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ADA  -  adenosine deaminase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), NFIA  -  nuclear factor i/a, DPYSL3  -  dihydropyrimidinase-like 3, TBC1D5  -  tbc1 domain family, member 5, ADCY3  -  adenylate cyclase 3, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, HLA-A  -  major histocompatibility complex, class i, a, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, STXBP1  -  syntaxin binding protein 1, TRIO  -  trio rho guanine nucleotide exchange factor, TBL1X  -  transducin (beta)-like 1x-linked, CUX1  -  cut-like homeobox 1, EPHB2  -  eph receptor b2, IRF2BPL  -  interferon regulatory factor 2 binding protein-like, MET  -  met proto-oncogene, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PLAUR  -  plasminogen activator, urokinase receptor, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, TCF4  -  transcription factor 4, ANXA1  -  annexin a1, RASSF5  -  ras association (ralgds/af-6) domain family member 5, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, WWOX  -  ww domain containing oxidoreductase, BBS4  -  bardet-biedl syndrome 4, ZNF827  -  zinc finger protein 827, LAMB1  -  laminin, beta 1]
GO:0050776	regulation of immune response	3.53E-4	8.5E-2	2.73	714	46	74	13	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, GPX1  -  glutathione peroxidase 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, MEF2C  -  myocyte enhancer factor 2c, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0022603	regulation of anatomical structure morphogenesis	4.04E-4	9.4E-2	2.10	714	92	74	20	[VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, HLA-G  -  major histocompatibility complex, class i, g, EPHB2  -  eph receptor b2, CUX1  -  cut-like homeobox 1, MYH10  -  myosin, heavy chain 10, non-muscle, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, PRICKLE1  -  prickle homolog 1 (drosophila), SDC2  -  syndecan 2, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, ADA  -  adenosine deaminase, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL2  -  dihydropyrimidinase-like 2, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0043067	regulation of programmed cell death	4.04E-4	9.09E-2	2.10	714	92	74	20	[VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, STXBP1  -  syntaxin binding protein 1, TRIO  -  trio rho guanine nucleotide exchange factor, HLA-G  -  major histocompatibility complex, class i, g, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, CPEB4  -  cytoplasmic polyadenylation element binding protein 4, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PLAUR  -  plasminogen activator, urokinase receptor, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, ADA  -  adenosine deaminase, RASSF5  -  ras association (ralgds/af-6) domain family member 5, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), WWOX  -  ww domain containing oxidoreductase]
GO:0030335	positive regulation of cell migration	4.28E-4	9.33E-2	3.22	714	30	74	10	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:2000147	positive regulation of cell motility	4.28E-4	9.04E-2	3.22	714	30	74	10	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:0043535	regulation of blood vessel endothelial cell migration	4.59E-4	9.39E-2	6.03	714	8	74	5	[MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0002705	positive regulation of leukocyte mediated immunity	4.59E-4	9.12E-2	6.03	714	8	74	5	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4.59E-4	8.86E-2	6.03	714	8	74	5	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ADA  -  adenosine deaminase, ANXA1  -  annexin a1]
GO:0002821	positive regulation of adaptive immune response	4.59E-4	8.61E-2	6.03	714	8	74	5	[HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, ADA  -  adenosine deaminase]
GO:0009968	negative regulation of signal transduction	4.79E-4	8.75E-2	2.34	714	66	74	16	[HLA-G  -  major histocompatibility complex, class i, g, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), KANK1  -  kn motif and ankyrin repeat domains 1, PXDN  -  peroxidasin homolog (drosophila), PRICKLE1  -  prickle homolog 1 (drosophila), PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), WWOX  -  ww domain containing oxidoreductase, ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1]
GO:0048870	cell motility	4.79E-4	8.51E-2	2.34	714	66	74	16	[DST  -  dystonin, MET  -  met proto-oncogene, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, MEF2C  -  myocyte enhancer factor 2c, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, BBS4  -  bardet-biedl syndrome 4, FAT1  -  fat atypical cadherin 1, ADCY3  -  adenylate cyclase 3, LAMB1  -  laminin, beta 1]
GO:0048518	positive regulation of biological process	4.89E-4	8.47E-2	1.38	714	349	74	50	[HLA-G  -  major histocompatibility complex, class i, g, ABAT  -  4-aminobutyrate aminotransferase, ZBTB20  -  zinc finger and btb domain containing 20, PBX1  -  pre-b-cell leukemia homeobox 1, NRP2  -  neuropilin 2, DPYSL3  -  dihydropyrimidinase-like 3, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, CUX1  -  cut-like homeobox 1, IRF2BPL  -  interferon regulatory factor 2 binding protein-like, PLAUR  -  plasminogen activator, urokinase receptor, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, AUTS2  -  autism susceptibility candidate 2, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, RASSF5  -  ras association (ralgds/af-6) domain family member 5, WWOX  -  ww domain containing oxidoreductase, CADM1  -  cell adhesion molecule 1, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, ARHGEF10  -  rho guanine nucleotide exchange factor (gef) 10, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, ADA  -  adenosine deaminase, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), NFIA  -  nuclear factor i/a, TBC1D5  -  tbc1 domain family, member 5, ADCY3  -  adenylate cyclase 3, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, TRIO  -  trio rho guanine nucleotide exchange factor, TBL1X  -  transducin (beta)-like 1x-linked, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1, ZNF827  -  zinc finger protein 827]
GO:0002715	regulation of natural killer cell mediated immunity	4.94E-4	8.33E-2	7.72	714	5	74	4	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0032655	regulation of interleukin-12 production	4.94E-4	8.13E-2	7.72	714	5	74	4	[HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, FOXP1  -  forkhead box p1]
GO:0042269	regulation of natural killer cell mediated cytotoxicity	4.94E-4	7.93E-2	7.72	714	5	74	4	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0032101	regulation of response to external stimulus	5.2E-4	8.16E-2	2.41	714	60	74	15	[EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, PLAUR  -  plasminogen activator, urokinase receptor, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ADA  -  adenosine deaminase, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, BBS4  -  bardet-biedl syndrome 4]
GO:0030334	regulation of cell migration	5.49E-4	8.43E-2	2.50	714	54	74	14	[MET  -  met proto-oncogene, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DPYSL3  -  dihydropyrimidinase-like 3, LAMB1  -  laminin, beta 1]
GO:0030198	extracellular matrix organization	5.68E-4	8.52E-2	4.82	714	12	74	6	[PXDN  -  peroxidasin homolog (drosophila), ST7  -  suppression of tumorigenicity 7, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MYO1E  -  myosin ie, LAMB1  -  laminin, beta 1]
GO:0040017	positive regulation of locomotion	5.8E-4	8.51E-2	3.11	714	31	74	10	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:0051272	positive regulation of cellular component movement	5.8E-4	8.32E-2	3.11	714	31	74	10	[NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), LAMB1  -  laminin, beta 1]
GO:0040012	regulation of locomotion	6.32E-4	8.89E-2	2.37	714	61	74	15	[MET  -  met proto-oncogene, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DPYSL3  -  dihydropyrimidinase-like 3, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1]
GO:0050678	regulation of epithelial cell proliferation	7.73E-4	1.06E-1	3.02	714	32	74	10	[VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, NFIB  -  nuclear factor i/b, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), PRKCA  -  protein kinase c, alpha, GPX1  -  glutathione peroxidase 1, LAMB1  -  laminin, beta 1]
GO:0002697	regulation of immune effector process	8.09E-4	1.09E-1	3.97	714	17	74	7	[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, STXBP1  -  syntaxin binding protein 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1]
GO:0045765	regulation of angiogenesis	8.09E-4	1.07E-1	3.97	714	17	74	7	[HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:1901342	regulation of vasculature development	8.09E-4	1.05E-1	3.97	714	17	74	7	[HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0097485	neuron projection guidance	8.59E-4	1.09E-1	3.22	714	27	74	9	[NFIB  -  nuclear factor i/b, NRP2  -  neuropilin 2, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, MYH10  -  myosin, heavy chain 10, non-muscle, DPYSL2  -  dihydropyrimidinase-like 2, EXT1  -  exostosin glycosyltransferase 1, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0007411	axon guidance	8.59E-4	1.07E-1	3.22	714	27	74	9	[NFIB  -  nuclear factor i/b, NRP2  -  neuropilin 2, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, MYH10  -  myosin, heavy chain 10, non-muscle, DPYSL2  -  dihydropyrimidinase-like 2, EXT1  -  exostosin glycosyltransferase 1, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0048583	regulation of response to stimulus	8.84E-4	1.09E-1	1.53	714	234	74	37	[CADM1  -  cell adhesion molecule 1, HLA-G  -  major histocompatibility complex, class i, g, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, ARHGEF10  -  rho guanine nucleotide exchange factor (gef) 10, KANK1  -  kn motif and ankyrin repeat domains 1, PXDN  -  peroxidasin homolog (drosophila), PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, TRIO  -  trio rho guanine nucleotide exchange factor, TBL1X  -  transducin (beta)-like 1x-linked, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, PLAUR  -  plasminogen activator, urokinase receptor, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, NUAK1  -  nuak family, snf1-like kinase, 1, MYO5A  -  myosin va (heavy chain 12, myoxin), PSD3  -  pleckstrin and sec7 domain containing 3, WWOX  -  ww domain containing oxidoreductase, BBS4  -  bardet-biedl syndrome 4]
GO:0051270	regulation of cellular component movement	9.22E-4	1.11E-1	2.30	714	63	74	15	[MET  -  met proto-oncogene, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DPYSL3  -  dihydropyrimidinase-like 3, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1]
GO:0002703	regulation of leukocyte mediated immunity	9.5E-4	1.12E-1	5.36	714	9	74	5	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g]
GO:0043062	extracellular structure organization	9.68E-4	1.13E-1	4.45	714	13	74	6	[PXDN  -  peroxidasin homolog (drosophila), ST7  -  suppression of tumorigenicity 7, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MYO1E  -  myosin ie, LAMB1  -  laminin, beta 1]
